Report - Journal of Cancer · Web viewTumoral Pyruvate Kinase L/R As A Predictive Marker For The Treatment Of Renal Cancer Patients With Sunitinib And Sorafenib. Marjut Niinivirta1,2, Gunilla

Please pass captcha verification before submit form